Biochemistry and Biotechnology Laboratory LR01ES05, Faculty of Sciences of Tunis, University of Tunis El Manar, El Manar II, 2092, Tunis, Tunisia.
Groupe de Recherche sur les Maladies Infectieuses en Production Animale (GREMIP), Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, QC, J2S 2M2, Canada.
World J Microbiol Biotechnol. 2023 May 24;39(8):205. doi: 10.1007/s11274-023-03648-7.
The present study aimed to evaluate the probiotic potential, α-amylase and α-glucosidase inhibitory effects, and β-galactosidase production of 19 non haemolytic lactic acid bacteria and bifidobacteria previously identified and isolated from honey bee gastrointestinal tract (BGIT) of Apis mellifera intermissa, honey, propolis and bee bread. The isolates were screened according to their high resistance to lysozyme and potent antibacterial activity. Our results indicated that among the 19 isolates, Limosilactobacillus fermentum BGIT12.2, Lactiplantibacillus plantarum BGIT13, Limosilactobacillus fermentum BGIT5.1 and Bifidobacterium asteroides BGIT8, isolated from BGIT exhibited a good tolerance to 100 mg/mL lysozyme (> 82%), excellent tolerance to 0.5% bile salt [survival rate (SR) ≥ 83.19% ± 0.01], and a high SR (≥ 80.0%) under gastrointestinal tract conditions. The auto-aggregation ability was high (auto-aggregation index ranging from 67.14 ± 0.16 to 92.8% ± 0.03) for L. fermentum BGIT12.2, L. plantarum BGIT13, and B. asteroides BGIT8, and moderate for L. fermentum BGIT5.1 (39.08% ± 0.11). Overall, the four isolates showed moderate co-aggregation capacity with pathogenic bacteria. They exhibited from moderate to high hydrophobicity towards toluene and xylene. The safety assessment revealed that the four isolates lacked gelatinase and mucinolytic activities. Also, they were susceptible to ampicillin, clindamycin, erythromycin, and chloramphenicol. Interestingly, the four isolates showed α-glucosidase and α-amylase inhibitory activities ranging from 37.08 ± 0.12 to 57.57% ± 0.1 and from 68.30 ± 0.09 to 79.42% ± 0.09, respectively. Moreover, L. fermentum BGIT12.2, L. plantarum BGIT13, L. fermentum BGIT5.1 isolates exhibited β-galactosidase activity over a wide range of 52.49 ± 0.24-746.54 ± 0.25 Miller Units. In conclusion, our findings suggest that the four isolates could be potential candidates for probiotics with interesting functional properties.
本研究旨在评估 19 株先前从 Apis mellifera intermissa 蜜蜂胃肠道(BGIT)、蜂蜜、蜂胶和蜂粮中分离和鉴定的非溶血乳酸菌和双歧杆菌的益生菌潜力、α-淀粉酶和 α-葡萄糖苷酶抑制作用以及β-半乳糖苷酶的产生。根据其对溶菌酶的高抗性和强大的抗菌活性对分离株进行了筛选。我们的结果表明,在 19 株分离株中,从 BGIT 分离的Limosilactobacillus fermentum BGIT12.2、Lactiplantibacillus plantarum BGIT13、Limosilactobacillus fermentum BGIT5.1 和 Bifidobacterium asteroides BGIT8 对 100mg/mL 溶菌酶具有良好的耐受性(>82%),对 0.5%胆汁盐具有极好的耐受性[存活率(SR)≥83.19%±0.01],并且在胃肠道条件下具有高 SR(≥80.0%)。L. fermentum BGIT12.2、L. plantarum BGIT13 和 B. asteroides BGIT8 的自聚集能力较高(自聚集指数范围为 67.14±0.16 至 92.8%±0.03),L. fermentum BGIT5.1 的自聚集能力中等(39.08%±0.11)。总体而言,这四个分离株与致病菌的共聚能力中等。它们对甲苯和二甲苯表现出从中等到高的疏水性。安全性评估显示,这四个分离株缺乏明胶酶和粘蛋白溶解活性。此外,它们对氨苄西林、克林霉素、红霉素和氯霉素敏感。有趣的是,这四个分离株的α-葡萄糖苷酶和α-淀粉酶抑制活性分别为 37.08%±0.12 至 57.57%±0.1 和 68.30%±0.09 至 79.42%±0.09。此外,L. fermentum BGIT12.2、L. plantarum BGIT13、L. fermentum BGIT5.1 分离株表现出β-半乳糖苷酶活性,范围为 52.49±0.24 至 746.54±0.25 Miller 单位。总之,我们的研究结果表明,这四个分离株可能是具有有趣功能特性的益生菌的潜在候选者。